Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$62.29
al cierre: Oct 24, 4:00 PM EDT
$62.29
0.000.00%
Pre-comercialización: Oct 24, 4:00 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Globus Medical Inc ha un obiettivo di prezzo di consenso pari a $84.08, stabilito in base alle ultime valutazioni degli analisti di 17. Le ultime 3 valutazioni degli analisti sono state rilasciate da Wells Fargo, Canaccord Genuity y Morgan Stanley il agosto 8, 2025, julio 22, 2025 y julio 15, 2025. Con un obiettivo di prezzo medio di $74.67 tra le Wells Fargo, Canaccord Genuity y Morgan Stanley, c'è un implicito 19.87% upside per Globus Medical Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Wells Fargo
Canaccord Genuity
Morgan Stanley
Truist Securities
Piper Sandler
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Globus Medical
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
08/08/2025 | 5.96% | Wells Fargo | $76 → $66 | Maintains | Overweight | |||
07/22/2025 | 44.49% | Canaccord Genuity | $97 → $90 | Maintains | Buy | |||
07/21/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
07/15/2025 | 9.17% | Morgan Stanley | $75 → $68 | Maintains | Overweight | |||
05/27/2025 | — | JMP Securities | — | Reiterates | Market Perform → Market Perform | |||
05/27/2025 | — | BTIG | — | Downgrade | Buy → Neutral | |||
05/12/2025 | 9.17% | Truist Securities | $80 → $68 | Maintains | Hold | |||
05/09/2025 | 23.62% | BTIG | $88 → $77 | Maintains | Buy | |||
05/09/2025 | 28.43% | Piper Sandler | $100 → $80 | Maintains | Overweight | |||
04/11/2025 | 28.43% | Truist Securities | $82 → $80 | Maintains | Hold | |||
04/09/2025 | 41.27% | BTIG | $94 → $88 | Maintains | Buy | |||
03/18/2025 | 31.64% | Truist Securities | $90 → $82 | Maintains | Hold | |||
03/18/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
02/24/2025 | — | Citizens Capital Markets | — | Reiterates | Market Perform → Market Perform | |||
02/24/2025 | 65.36% | Barclays | $100 → $103 | Maintains | Overweight | |||
02/21/2025 | 50.91% | BTIG | $91 → $94 | Maintains | Buy | |||
02/21/2025 | 50.91% | Stifel | $92 → $94 | Maintains | Buy | |||
02/21/2025 | 49.3% | Wells Fargo | $95 → $93 | Maintains | Overweight | |||
02/21/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
02/06/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
01/10/2025 | 62.14% | Canaccord Genuity | $92 → $101 | Maintains | Buy | |||
01/09/2025 | 55.72% | B of A Securities | $80 → $97 | Upgrade | Underperform → Neutral | |||
01/09/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
12/18/2024 | 44.49% | Truist Securities | $85 → $90 | Maintains | Hold | |||
12/17/2024 | 84.62% | Roth MKM | $100 → $115 | Maintains | Buy | |||
12/12/2024 | 46.09% | BTIG | $87 → $91 | Maintains | Buy | |||
12/11/2024 | 52.51% | Wells Fargo | $88 → $95 | Maintains | Overweight | |||
12/09/2024 | 47.7% | Canaccord Genuity | $85 → $92 | Maintains | Buy | |||
12/02/2024 | 60.54% | Morgan Stanley | $83 → $100 | Upgrade | Equal-Weight → Overweight | |||
11/11/2024 | 33.25% | Morgan Stanley | $74 → $83 | Maintains | Equal-Weight | |||
11/07/2024 | 60.54% | Barclays | $93 → $100 | Maintains | Overweight | |||
11/07/2024 | — | Needham | — | Reiterates | → Hold | |||
11/06/2024 | 47.7% | Stifel | $80 → $92 | Maintains | Buy | |||
11/06/2024 | 36.46% | Canaccord Genuity | $79 → $85 | Maintains | Buy | |||
11/06/2024 | 60.54% | Roth MKM | $100 → $100 | Reiterates | Buy → Buy | |||
11/06/2024 | 47.7% | RBC Capital | $80 → $92 | Maintains | Outperform | |||
11/06/2024 | 41.27% | Wells Fargo | $78 → $88 | Maintains | Overweight | |||
11/06/2024 | 60.54% | Piper Sandler | $80 → $100 | Maintains | Overweight | |||
11/06/2024 | 28.43% | B of A Securities | $55 → $80 | Maintains | Underperform | |||
11/06/2024 | — | Needham | — | Reiterates | → Hold | |||
10/14/2024 | 25.22% | BTIG | $77 → $78 | Maintains | Buy | |||
10/08/2024 | 28.43% | RBC Capital | $78 → $80 | Maintains | Outperform | |||
08/28/2024 | 23.62% | BTIG | $75 → $77 | Maintains | Buy | |||
08/08/2024 | 49.3% | Barclays | $85 → $93 | Maintains | Overweight | |||
08/07/2024 | 25.22% | RBC Capital | $76 → $78 | Maintains | Outperform | |||
08/07/2024 | 26.83% | Truist Securities | $78 → $79 | Maintains | Hold | |||
08/07/2024 | 25.22% | Wells Fargo | $60 → $78 | Upgrade | Equal-Weight → Overweight | |||
08/07/2024 | — | Needham | — | Reiterates | → Hold | |||
07/16/2024 | 25.22% | Truist Securities | $63 → $78 | Maintains | Hold | |||
07/15/2024 | 20.4% | BTIG | $72 → $75 | Maintains | Buy | |||
07/15/2024 | 13.98% | Morgan Stanley | $67 → $71 | Maintains | Equal-Weight | |||
05/29/2024 | 15.59% | BTIG | $63 → $72 | Maintains | Buy | |||
05/20/2024 | 28.43% | Piper Sandler | $60 → $80 | Upgrade | Neutral → Overweight | |||
05/09/2024 | 36.46% | Barclays | $83 → $85 | Maintains | Overweight | |||
05/08/2024 | 1.14% | BTIG | $60 → $63 | Maintains | Buy | |||
05/08/2024 | -3.68% | Piper Sandler | $55 → $60 | Maintains | Neutral | |||
05/08/2024 | 12.38% | Stifel | $64 → $70 | Maintains | Buy | |||
05/08/2024 | — | Needham | — | Reiterates | → Hold | |||
03/18/2024 | -3.68% | BTIG | → $60 | Upgrade | Neutral → Buy | |||
02/21/2024 | 26.83% | Canaccord Genuity | → $79 | Reiterates | Buy → Buy | |||
02/21/2024 | -3.68% | Truist Securities | $58 → $60 | Maintains | Hold | |||
01/11/2024 | 12.38% | RBC Capital | $70 → $70 | Reiterates | Outperform → Outperform | |||
12/22/2023 | -6.89% | Truist Securities | $53 → $58 | Maintains | Hold | |||
12/20/2023 | 13.98% | Canaccord Genuity | $67 → $71 | Maintains | Buy | |||
11/14/2023 | -14.91% | Morgan Stanley | $60 → $53 | Maintains | Equal-Weight | |||
11/08/2023 | -14.91% | Truist Securities | $58 → $53 | Maintains | Hold | |||
10/20/2023 | 20.4% | Roth MKM | → $75 | Initiates | → Buy | |||
10/12/2023 | 38.06% | Barclays | $77 → $86 | Maintains | Overweight | |||
09/19/2023 | -2.07% | Stifel | → $61 | Upgrade | Hold → Buy | |||
09/15/2023 | -6.89% | Wells Fargo | $63 → $58 | Maintains | Equal-Weight | |||
09/05/2023 | 4.35% | Truist Securities | → $65 | Reiterates | Hold → Hold | |||
08/07/2023 | 4.35% | Truist Securities | $68 → $65 | Maintains | Hold | |||
08/07/2023 | 23.62% | Barclays | $75 → $77 | Maintains | Overweight | |||
08/04/2023 | 1.14% | Wells Fargo | $61 → $63 | Maintains | Equal-Weight | |||
07/19/2023 | 9.17% | Truist Securities | $64 → $68 | Maintains | Hold | |||
05/31/2023 | -3.68% | Morgan Stanley | $64 → $60 | Maintains | Equal-Weight | |||
05/24/2023 | — | JMP Securities | — | Reiterates | → Market Perform | |||
05/05/2023 | 2.75% | Truist Securities | $66 → $64 | Maintains | Hold | |||
03/30/2023 | 7.56% | Canaccord Genuity | → $67 | Upgrade | Hold → Buy | |||
03/28/2023 | 7.56% | Canaccord Genuity | → $67 | Reiterates | → Hold | |||
02/22/2023 | 2.75% | Morgan Stanley | $78 → $64 | Maintains | Equal-Weight | |||
02/22/2023 | 7.56% | Canaccord Genuity | $75 → $67 | Maintains | Hold | |||
02/22/2023 | -2.07% | Wells Fargo | $67 → $61 | Maintains | Equal-Weight | |||
02/13/2023 | 1.14% | B of A Securities | $83 → $63 | Downgrade | Buy → Underperform | |||
02/10/2023 | 7.56% | Wells Fargo | $82 → $67 | Downgrade | Overweight → Equal-Weight | |||
02/10/2023 | 12.38% | Truist Securities | → $70 | Downgrade | Buy → Hold | |||
02/10/2023 | 12.38% | Loop Capital | $90 → $70 | Downgrade | Buy → Hold | |||
02/10/2023 | — | Needham | — | Downgrade | Buy → Hold | |||
02/10/2023 | — | BTIG | — | Downgrade | Buy → Neutral | |||
02/09/2023 | — | Piper Sandler | — | Downgrade | Overweight → Neutral | |||
01/06/2023 | 25.22% | Morgan Stanley | $68 → $78 | Maintains | Equal-Weight | |||
12/20/2022 | 36.46% | Truist Securities | $74 → $85 | Maintains | Buy | |||
12/12/2022 | 31.64% | Wells Fargo | $74 → $82 | Maintains | Overweight | |||
11/09/2022 | 9.17% | Morgan Stanley | $66 → $68 | Maintains | Equal-Weight |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Globus Medical (GMED)?
El último precio objetivo de Globus Medical (NYSE:GMED) fue comunicado por Wells Fargo el agosto 8, 2025. La firma de analistas fijó un precio objetivo para $66.00 que espera GMED a rise dentro de 12 meses (un posible 5.96% upside). 40 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Globus Medical (GMED)?
La última calificación de analistas para Globus Medical (NYSE:GMED) fue proporcionada por Wells Fargo, y Globus Medical mantuvo su overweight calificación.
¿Cuándo se produjo la última revisión al alza de Globus Medical (GMED)?
La última revisión al alza de Globus Medical Inc se produjo en enero 9, 2025, cuando B of A Securities elevó su precio objetivo a $97. B of A Securities anteriormente tenía an underperform para Globus Medical Inc.
¿Cuándo fue la última revisión a la baja de Globus Medical (GMED)?
La última revisión a la baja de Globus Medical Inc se produjo en mayo 27, 2025, cuando BTIG cambió su precio objetivo de N/A a N/A para Globus Medical Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Globus Medical (GMED)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Globus Medical, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Globus Medical se registró el agosto 8, 2025, por lo que la próxima calificación estará disponible en torno al agosto 8, 2026.
¿Es correcta la calificación de los analistas sobre Globus Medical (GMED)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Globus Medical (GMED) fue un mantuvo con un precio objetivo de $76.00 a $66.00. El precio actual al que cotiza Globus Medical (GMED) es de $62.29, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.